Selected research
Industry Growth & Trends
Global Omics Data Analysis Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Omics Data Analysis Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Omics Data Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Omics Data Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Omics Data Analysis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Omics Data Analysis Service market include Acobiom, AltraBio, BGI Genomics, Biogenity, Tempus, Cmbio, Creative Proteomics, Firalis Molecular Precision and Metware Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Omics Data Analysis Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Omics Data Analysis Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Omics Data Analysis Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Omics Data Analysis Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Omics Data Analysis Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Omics Data Analysis Service Market by Company
Acobiom
AltraBio
BGI Genomics
Biogenity
Tempus
Cmbio
Creative Proteomics
Firalis Molecular Precision
Metware Biotechnology
Nuvisan
Omics Data Solutions
PharmaLex
Standard BioTools
PIPA AI
Seven Bridges
Omics Data Analysis Service Segment by Type
Genomic Analysis
Transcriptomic Analysis
Proteomic Analysis
Metabolomic Analysis
Epigenomic Analysis
Microbiome Analysis
Others
Omics Data Analysis Service Segment by Application
Developmental Biology
Clinical Medicine
Precision Diagnosis
Drug Development
Others
Omics Data Analysis Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omics Data Analysis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Omics Data Analysis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omics Data Analysis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Omics Data Analysis Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Genomic Analysis
- Transcriptomic Analysis
- Proteomic Analysis
- Metabolomic Analysis
- Epigenomic Analysis
- Microbiome Analysis
- Others
Applications
- Developmental Biology
- Clinical Medicine
- Precision Diagnosis
- Drug Development
- Others
Companies covered
- Acobiom
- AltraBio
- BGI Genomics
- Biogenity
- Tempus
- Cmbio
- Creative Proteomics
- Firalis Molecular Precision
- Metware Biotechnology
- Nuvisan
- Omics Data Solutions
- PharmaLex
- Standard BioTools
- PIPA AI
- Seven Bridges
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Omics Data Analysis Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Omics Data Analysis Service Market Size by Region (2021-2032)
- 1.4.1 Global Omics Data Analysis Service Market Size by Region (2021-2026)
- 1.4.2 Global Omics Data Analysis Service Market Size by Region (2027-2032)
- 1.5 Key Regions Omics Data Analysis Service Market Size (2021-2032)
- 1.5.1 North America Omics Data Analysis Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Omics Data Analysis Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Omics Data Analysis Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Omics Data Analysis Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Omics Data Analysis Service Market Size Growth Rate (2021-2032)
2 Omics Data Analysis Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Genomic Analysis
- 2.1.2 Transcriptomic Analysis
- 2.1.3 Proteomic Analysis
- 2.1.4 Metabolomic Analysis
- 2.1.5 Epigenomic Analysis
- 2.1.6 Microbiome Analysis
- 2.1.7 Others
- 2.2 Global Omics Data Analysis Service Market Size by Type
- 2.2.1 Global Omics Data Analysis Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Omics Data Analysis Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Omics Data Analysis Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Omics Data Analysis Service Market Size by Regions
- 2.3.1 North America Omics Data Analysis Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Omics Data Analysis Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Omics Data Analysis Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Omics Data Analysis Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Omics Data Analysis Service Market Size Breakdown by Type (2021-2026)
3 Omics Data Analysis Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Developmental Biology
- 3.1.2 Clinical Medicine
- 3.1.3 Precision Diagnosis
- 3.1.4 Drug Development
- 3.1.5 Others
- 3.2 Global Omics Data Analysis Service Market Size by Application
- 3.2.1 Global Omics Data Analysis Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Omics Data Analysis Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Omics Data Analysis Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Omics Data Analysis Service Market Size by Regions
- 3.3.1 North America Omics Data Analysis Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Omics Data Analysis Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Omics Data Analysis Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Omics Data Analysis Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Omics Data Analysis Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Omics Data Analysis Service Industry Trends
- 4.2 Omics Data Analysis Service Industry Drivers
- 4.3 Omics Data Analysis Service Industry Opportunities and Challenges
- 4.4 Omics Data Analysis Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Omics Data Analysis Service Revenue (2021-2026)
- 5.2 Global Omics Data Analysis Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Omics Data Analysis Service Key Company Headquarters & Area Served
- 5.4 Global Omics Data Analysis Service Company, Product Type & Application
- 5.5 Global Omics Data Analysis Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Omics Data Analysis Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Omics Data Analysis Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Omics Data Analysis Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Acobiom
- 6.1.1 Acobiom Company Information
- 6.1.2 Acobiom Business Overview
- 6.1.3 Acobiom Omics Data Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Acobiom Omics Data Analysis Service Product Portfolio
- 6.1.5 Acobiom Recent Developments
- 6.2 AltraBio
- 6.2.1 AltraBio Company Information
- 6.2.2 AltraBio Business Overview
- 6.2.3 AltraBio Omics Data Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 AltraBio Omics Data Analysis Service Product Portfolio
- 6.2.5 AltraBio Recent Developments
- 6.3 BGI Genomics
- 6.3.1 BGI Genomics Company Information
- 6.3.2 BGI Genomics Business Overview
- 6.3.3 BGI Genomics Omics Data Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 BGI Genomics Omics Data Analysis Service Product Portfolio
- 6.3.5 BGI Genomics Recent Developments
- 6.4 Biogenity
- 6.4.1 Biogenity Company Information
- 6.4.2 Biogenity Business Overview
- 6.4.3 Biogenity Omics Data Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Biogenity Omics Data Analysis Service Product Portfolio
- 6.4.5 Biogenity Recent Developments
- 6.5 Tempus
- 6.5.1 Tempus Company Information
- 6.5.2 Tempus Business Overview
- 6.5.3 Tempus Omics Data Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Tempus Omics Data Analysis Service Product Portfolio
- 6.5.5 Tempus Recent Developments
- 6.6 Cmbio
- 6.6.1 Cmbio Company Information
- 6.6.2 Cmbio Business Overview
- 6.6.3 Cmbio Omics Data Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Cmbio Omics Data Analysis Service Product Portfolio
- 6.6.5 Cmbio Recent Developments
- 6.7 Creative Proteomics
- 6.7.1 Creative Proteomics Company Information
- 6.7.2 Creative Proteomics Business Overview
- 6.7.3 Creative Proteomics Omics Data Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Creative Proteomics Omics Data Analysis Service Product Portfolio
- 6.7.5 Creative Proteomics Recent Developments
- 6.8 Firalis Molecular Precision
- 6.8.1 Firalis Molecular Precision Company Information
- 6.8.2 Firalis Molecular Precision Business Overview
- 6.8.3 Firalis Molecular Precision Omics Data Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Firalis Molecular Precision Omics Data Analysis Service Product Portfolio
- 6.8.5 Firalis Molecular Precision Recent Developments
- 6.9 Metware Biotechnology
- 6.9.1 Metware Biotechnology Company Information
- 6.9.2 Metware Biotechnology Business Overview
- 6.9.3 Metware Biotechnology Omics Data Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Metware Biotechnology Omics Data Analysis Service Product Portfolio
- 6.9.5 Metware Biotechnology Recent Developments
- 6.10 Nuvisan
- 6.10.1 Nuvisan Company Information
- 6.10.2 Nuvisan Business Overview
- 6.10.3 Nuvisan Omics Data Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Nuvisan Omics Data Analysis Service Product Portfolio
- 6.10.5 Nuvisan Recent Developments
- 6.11 Omics Data Solutions
- 6.11.1 Omics Data Solutions Company Information
- 6.11.2 Omics Data Solutions Business Overview
- 6.11.3 Omics Data Solutions Omics Data Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Omics Data Solutions Omics Data Analysis Service Product Portfolio
- 6.11.5 Omics Data Solutions Recent Developments
- 6.12 PharmaLex
- 6.12.1 PharmaLex Company Information
- 6.12.2 PharmaLex Business Overview
- 6.12.3 PharmaLex Omics Data Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 PharmaLex Omics Data Analysis Service Product Portfolio
- 6.12.5 PharmaLex Recent Developments
- 6.13 Standard BioTools
- 6.13.1 Standard BioTools Company Information
- 6.13.2 Standard BioTools Business Overview
- 6.13.3 Standard BioTools Omics Data Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Standard BioTools Omics Data Analysis Service Product Portfolio
- 6.13.5 Standard BioTools Recent Developments
- 6.14 PIPA AI
- 6.14.1 PIPA AI Company Information
- 6.14.2 PIPA AI Business Overview
- 6.14.3 PIPA AI Omics Data Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 PIPA AI Omics Data Analysis Service Product Portfolio
- 6.14.5 PIPA AI Recent Developments
- 6.15 Seven Bridges
- 6.15.1 Seven Bridges Company Information
- 6.15.2 Seven Bridges Business Overview
- 6.15.3 Seven Bridges Omics Data Analysis Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Seven Bridges Omics Data Analysis Service Product Portfolio
- 6.15.5 Seven Bridges Recent Developments
7 North America
- 7.1 North America Omics Data Analysis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Omics Data Analysis Service Market Size by Country (2021-2026)
- 7.3 North America Omics Data Analysis Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Omics Data Analysis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Omics Data Analysis Service Market Size by Country (2021-2026)
- 8.3 Europe Omics Data Analysis Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Omics Data Analysis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Omics Data Analysis Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Omics Data Analysis Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Omics Data Analysis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Omics Data Analysis Service Market Size by Country (2021-2026)
- 10.3 South America Omics Data Analysis Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Omics Data Analysis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Omics Data Analysis Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Omics Data Analysis Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst